LWANC
HOOK

Laurel Wealth Advisors (North Carolina)’s HOOKIPA Pharma HOOK Stock Holding History

Laurel Wealth Advisors (North Carolina)’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18
Closed – – 658
2022
Q1 		$0 Hold
18
– – ﹤0.01% 681
2021
Q4 		$0 Hold
18
– – ﹤0.01% 679
2021
Q3 		$1K Hold
18
– – ﹤0.01% 641
2021
Q2 		$2K Buy
+18
New +$2.4K ﹤0.01% 668

Other funds holding HOOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Laurel Wealth Advisors (North Carolina)'s HOOK Position: Q2 2022 in Review

Laurel Wealth Advisors (North Carolina) sold out of HOOKIPA Pharma (HOOK) in Q2 2022, closing a stake of 18 shares.

Laurel Wealth Advisors (North Carolina) first reported a position in HOOK in Q2 2021 and held it in 4 quarters. The position peaked at $2K in Q2 2021. 58 funds tracked by Wall St. Rank hold HOOK as of Q2 2022.

  • Laurel Wealth Advisors (North Carolina) reported no remaining HOOKIPA Pharma position as of Q2 2022 after selling out during the quarter.
  • Laurel Wealth Advisors (North Carolina) sold 18 HOOKIPA Pharma shares in Q2 2022.
  • Laurel Wealth Advisors (North Carolina) first reported a position in HOOKIPA Pharma in Q2 2021 and held it in 4 quarters.
  • Laurel Wealth Advisors (North Carolina)'s HOOKIPA Pharma position peaked at $2K in Q2 2021.
  • 58 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2022.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q2 2022, filed 12 Aug 2022.